AQR Capital Management
PTLA

AQR Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

AQR Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-68,195
Closed -$1.63M – 2224
2019
Q4 		$1.63M Buy
68,195
+9,393
+16% +$259K ﹤0.01% 1343
2019
Q3 		$1.58M Buy
58,802
+2,567
+5% +$72.1K ﹤0.01% 1374
2019
Q2 		$1.53M Hold
56,235
– – ﹤0.01% 1355
2019
Q1 		$1.95M Buy
56,235
+3,832
+7% +$111K ﹤0.01% 1328
2018
Q4 		$1.02M Hold
52,403
– – ﹤0.01% 1503
2018
Q3 		$1.4M Buy
52,403
+1,447
+3% +$47.2K ﹤0.01% 1560
2018
Q2 		$1.93M Sell
50,956
-26,241
-34% -$1M ﹤0.01% 1436
2018
Q1 		$2.52M Sell
77,197
-2,914
-4% -$128K ﹤0.01% 1253
2017
Q4 		$3.9M Sell
80,111
-1,694
-2% -$85.7K ﹤0.01% 1121
2017
Q3 		$4.42M Buy
81,805
+19,418
+31% +$1.14M 0.01% 1067
2017
Q2 		$3.5M Buy
62,387
+27,572
+79% +$1.1M ﹤0.01% 1168
2017
Q1 		$1.36M Buy
+34,815
New +$1.11M ﹤0.01% 1552
2016
Q2 		– Sell
-22,397
Closed -$457K – 2296
2016
Q1 		$457K Sell
22,397
-17,737
-44% -$563K ﹤0.01% 1870
2015
Q4 		$2.06M Buy
40,134
+2,234
+6% +$108K ﹤0.01% 1222
2015
Q3 		$1.61M Sell
37,900
-1,656
-4% -$79.9K ﹤0.01% 1228
2015
Q2 		$1.8M Buy
39,556
+33,356
+538% +$1.34M ﹤0.01% 1224
2015
Q1 		$235K Buy
+6,200
New +$213K ﹤0.01% 1965
2013
Q4 		– Sell
-19,500
Closed -$522K – 2625
2013
Q3 		$522K Buy
+19,500
New +$464K ﹤0.01% 1959

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

AQR Capital Management's PTLA Position: Q1 2020 in Review

AQR Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 68,195 shares — an estimated $1.63M sold.

AQR Capital Management first reported a position in PTLA in Q3 2013 and held it in 18 quarters. The position peaked at $4.42M in Q3 2017. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • AQR Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • AQR Capital Management sold 68,195 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.63M.
  • AQR Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q3 2013 and held it in 18 quarters.
  • AQR Capital Management's Portola Pharmaceuticals, Inc. position peaked at $4.42M in Q3 2017.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on AQR Capital Management's 13F filing for Q1 2020, filed 15 May 2020.